GlassScriptPhysician profile
Karlee M Walther
NPI 1780042614
$6,215.14
in general payments reported to CMS, 2019-2025
18 companies · $78.96 in 2025
The $78.96 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,092 · 2022: $1,774 · 2023: $2,123 · 2024: $1,147 · 2025: $78.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,250 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,250.43 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,675.09 | 2021-2024 | |
| Janssen Biotech, INC. | $551.47 | 2021-2024 | Tremfya, Simponi, Remicade |
| Lilly USA, LLC | $518.28 | 2021-2024 | Olumiant, Taltz |
| Novartis Pharmaceuticals Corporation | $449.46 | 2021-2024 | |
| Amgen INC. | $371.05 | 2021-2024 | Otezla |
| Regeneron Healthcare Solutions, INC. | $250.93 | 2021-2024 | Dupixent |
| Genzyme Corporation | $221.48 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $220.99 | 2022-2024 | Sotyktu |
| Incyte Corporation | $166.94 | 2022-2024 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.17 | 2022-2024 | Spevigo, Cyltezo |
| Pfizer INC. | $151.75 | 2022-2023 | |
| Ucb, INC. | $131.76 | 2021-2024 | Bimzelx, Cimzia |
| Leo Pharma INC. | $102.57 | 2021-2022 | |
| Organogenesis INC. | $78.96 | 2025 | Via Matrix |
| Dermavant Sciences, INC. | $62.84 | 2023 | Vtama |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $54.26 | 2021-2024 | Aklief, Oracea |
| Revance Therapeutics, INC. | $28.33 | 2024 | |
| Sun Pharmaceutical Industries INC. | $21.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karlee Walther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.